SME (Subject Matter Expertise) for the Pharmaceutical, Clinical Research & Life Sciences Industry trained in the United Kingdom at Premark services in an 8-week program (2005) with exclusive focus on Strategic Market Intelligence  

• End-to-end monitoring of the competitive landscape, For example -bifurcating insights into Clinical CI (R&D pipeline, trial design shifts, MoA breakthroughs) and Commercial CI (pricing, market entry / Go to Market strategy, field force changes, and launch paths) 

• Strategic Framework Application: Synthesize complex market signals into actionable strategies using structured frameworks such as SWOT, PESTLE, Porter’s Five Forces, and Patient Journey Mapping to identify unmet needs and white-space opportunities. 

• Rapid secondary research synthesis  with GenAI tools : For Example – automated earnings call sentiment analysis, or GPT-based clinical trial summarization to increase the velocity and depth of strategic recommendations. 

• Insights on Conference Coverage (ASCO, ESMO, AACR, JP Morgan, Jefferies, etc.): Provide pre-conference/ post-conference impact assessment analysis of competitor data readouts on Pharma company portfolio 

• Strategic Advisory: Transform market insights from public & proprietary data sources (e.g. CT.gov, Clarivate, Evaluate Pharma) into “Decision Making Stories” which provide clear “So What?” and “Now What?” recommendations to partners & senior leadership. 

• Predictive Intelligence: Flag “Trigger Events” (e.g., Breakthrough Designations, FDA/ regulatory signals, M&A activity) and perform Scenario Planning to assess potential implications for pharmaceutical brands. 

Visit Discover Insights – Cases, Blogs, News, podcasts and Whitepapers on Business Research/ Market Intelligence/ Competitive Intelligence https://rashmipant.com/discover-insight/